Gilead Sciences Inc. (Nasdaq: GILD) will acquire YM BioSciences Inc. (NYSE: YMI) for about $510 million.
The deal amounts to about $2.95 per share.
Complete access to real-time information and analysis of news and trends in the industry.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In